NASDAQ: MRSN       Mersana Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
7.42   -0.50 (6.31%)  7.36 - 8.00  250,300


Avg Volume (4 weeks):590,233
4 Weeks Range:5.09 - 8.93
4 Weeks Price Volatility (%):
52 Weeks Range:1.32 - 8.93
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Mersana Therapeutics Inc is a clinical stage biopharmaceutical company. It is focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need. The company's most advanced platform, Dolaflexin, has been used to generate a pipeline of proprietary ADC product candidates to address patient populations that are not currently amenable to treatment with traditional ADC-based therapies. Its lead product candidate, XMT-1522, is a HER2-targeted ADC is in a Phase 1 dose escalation study in primarily breast cancer patients as well as non-small cell lung cancer (NSCLC) and gastric cancer.

  Be the first to like this.


1843  6298  540  225 

Top 10 Active Counters
 VXX 14.24+0.75 
 EEM 44.60-0.36 
 SPY 328.77-2.95 
 INTC 68.47+5.15 
 AMD 50.35-1.36 
 CHK 0.558-0.015 
 F 9.00-0.14 
 NIO 4.66-0.26 
 AVP 5.60-0.05 
 GE 11.71-0.06 
Partners & Brokers